HealthCode Bio

Shanghai, China · Founded 2015 · Privately Held (backing)

Developer of health assessment and disease diagnostic reagents and microchips, designed for modern biotechnological solutions. HealthCode Bio is based in Shanghai, China and was founded in 2015. Its last reported valuation was $418 million in May 2022.

Last reported valuation
$417.9M
Oct 2026
Priced at
—
Total raised
—
Last round
—

Who backs HealthCode Bio?

3 investors
InvestorType
Wuxi Industry Development GroupOther
Cathy Fortune Corporation—
Shanghai Huamin Investment—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

HealthCode Bio investors

3 investors are on record for HealthCode Bio, including Wuxi Industry Development Group, Cathy Fortune Corporation and Shanghai Huamin Investment.

Free account
More of HealthCode Bio with a free account
  • ·Watch HealthCode Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 3 firms already write checks for companies like HealthCode Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View